CompletedNot Applicable

Education-Based İntervention Program for Persons With Chronic Obstructive Pulmonary Disease (EBIPCOPD)

Turkey (Türkiye)40 participantsStarted 2019-03-04

Plain-language summary

Obstructive Pulmonary Disease(COPD) treatment, leading to the role of nurses to become more and more important. An Education-Based Intervention Program(EBIP) consists of several steps that aim to achieve better health outcomes through guidingCOPD patients to reduce dyspnea symptoms and improve chronic self-care management skills. The aim of this study is to evaluate the dyspnea and chronic self-care management outcomes of EBIP compared to routine care. Research Hypotheses: H0: EBIP has no effect on dyspnea or chronic self-care management in COPD patients. H1: EBIP effects dyspnea outcomes of COPD patients. H2: EBIP effects chronic self-care management outcomes of COPD patients.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Individuals to be included in the study are 18 years of age and over * have been diagnosed with COPD Stage 2 for six months or more, * not having been in hospital for one month after discharge, - no communication problems, * lack of mental confusion, * conscious and complete orientation * volunteering to participate in the research, * It is planned to be conducted with patients living in the center of Kars. Exclusion Criteria: * Being 18 years old and under, * KOAH stage 1, 2, 4 diagnosed, * being a communication problem, * having mental confusion or * having any psychiatric problem, * not volunteering to participate in the research, * Living outside the Kars center

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

pulmonary function test(PFT)

Timeframe: Change from PFT at 3 months

Baseline Dyspnea Index(BDI)

Timeframe: Change from BDI at 3 months

Self-Care Management Scale in Chronic Diseases(SCMP-G)

Timeframe: Change from SCMP-G at 3 months

Trial details

NCT IDNCT04260178

SponsorGönül GÖKÇAY

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-04

View on ClinicalTrials.gov More Chronic Obstructive Pulmonary Disease trials